BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Everything You Need to Know About the FDA Peptide Ban FDA Compliance for Peptide Therapy and BPC 157 Holt Law